Target intelligence / Profile preview

ADGB divergent transcript (ADGB-DT)

Target
ADGB-DT
Molecular classification
Long noncoding RNA (lncRNA), Divergent transcript
01

Overview

ADGB divergent transcript (ADGB-DT) refers to a noncoding RNA produced by divergent transcription at the promoter region of the ADGB gene. Divergent transcription is a phenomenon wherein active gene promoters initiate transcription in both sense and antisense directions, often giving rise to a long noncoding RNA from the antisense direction[2][1]. Such transcripts are often unstable, lowly expressed, and their biological significance remains largely unclear. In some cases, divergent lncRNAs have been linked to regulation of gene expression—typically of adjacent transcription factors or development-related genes—but there is currently no evidence that ADGB-DT functions as an independent molecular target or pharmacological entity[2][4]. The term "ADGB divergent transcript" is used in transcriptomics to denote such antisense, noncoding RNAs but does not indicate a validated protein-coding gene or druggable target.

Other names
ADGB-DTADGB divergent transcriptdivergent lncRNA at ADGB locus
02

Biological functions

Possible regulation of local gene expressionTranscriptional regulation (by analogy to other divergent lncRNAs)
03

Disease associations

Other

Beyond the preview

Go deeper on ADGB divergent transcript (ADGB-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADGB divergent transcript (ADGB-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call